Carbyne Biometrics v. Apple: Fraud Detection Patent Dispute Dismissed at Federal Circuit
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Carbyne Biometrics, LLC v. Apple, Inc. |
| Case Number | 25-2125 (Fed. Cir.) |
| Court | Federal Circuit, Appeal from District of Columbia circuit jurisdiction |
| Duration | Sep 2025 – Mar 2026 174 days |
| Outcome | Voluntary Dismissal (Cost-neutral) |
| Patents at Issue | |
| Accused Products | Apple’s Biometric Authentication Ecosystem (e.g., Face ID, Touch ID, Apple Pay) |
Introduction
In a case that quietly concluded after 174 days of appellate proceedings, Carbyne Biometrics, LLC v. Apple, Inc. (Case No. 25-2125) ended with a voluntary dismissal at the Court of Appeals for the Federal Circuit, with each party bearing its own costs. Filed on September 19, 2025, and closed on March 12, 2026, the dispute centered on US Patent No. 9,972,010 — a method-based patent covering fraud reduction technology with biometric applications.
The case is a notable example of patent invalidity/cancellation proceedings reaching the appellate level before settling into a negotiated exit. For patent attorneys tracking biometric fraud detection patent litigation and IP professionals monitoring Apple’s defensive patent posture, this dismissal carries meaningful strategic signals — even in the absence of a merits ruling. It also illustrates a broader trend of NPE (non-practicing entity) assertions against major technology firms resolving before appellate courts issue substantive decisions.
Case Overview
The Parties
⚖️ Plaintiff
A patent assertion entity focused on biometric and identity verification technologies, commonly used to monetize patents in high-value technology sectors.
🛡️ Defendant
One of the world’s most valuable technology companies, maintaining an extensive IP portfolio and defending against patent assertion across biometric authentication, mobile security, and fraud prevention domains.
The Patent at Issue
This case involved **US Patent No. 9,972,010 B1 (Application No. 13/875,245)** covering a method, medium, and system for reducing fraudulent activity with biometric applications.
- • US9,972,010 B1 — Method, medium, and system for reducing fraud (biometric applications)
Developing a biometric fraud solution?
Check if your technology might infringe this or related patents.
Litigation Timeline & Procedural History
| Appeal Filed | September 19, 2025 |
| Case Closed | March 12, 2026 |
| Total Duration | 174 days |
The appeal was filed in the **District of Columbia circuit jurisdiction** and adjudicated at the **Court of Appeals for the Federal Circuit** — the exclusive appellate venue for U.S. patent disputes. The Federal Circuit’s specialized jurisdiction over patent law makes every dismissal at this level procedurally significant, even when no merits ruling is issued.
The 174-day duration from filing to closure is relatively brief for Federal Circuit proceedings, where fully briefed appeals routinely extend 12–24 months. This compressed timeline strongly suggests the parties reached a resolution — or one party withdrew strategically — well before substantive briefing concluded.
The **verdict cause is classified as Patentability / Invalidity-Cancellation**, indicating the appeal arose from a challenge to the patent’s validity, likely originating from a **USPTO inter partes review (IPR)**, **PTAB proceeding**, or district court invalidity ruling. Specific underlying proceedings were not disclosed in the available case data.
The Verdict & Legal Analysis
Outcome
The Federal Circuit dismissed Case No. 25-2125 pursuant to Federal Rule of Appellate Procedure 42(b), which governs voluntary dismissals at the appellate level. The court’s order was unambiguous: proceedings dismissed, each side to bear its own costs.
No damages were awarded. No injunctive relief was issued. No claim construction ruling was published. The case terminated without a precedential opinion.
Key Legal Issues
The classified **verdict cause — Invalidity/Cancellation Action** — is substantively important. This framing indicates the core dispute was not whether Apple infringed US9,972,010, but whether the patent itself was valid and should survive legal scrutiny. Common bases for invalidity proceedings at this stage include:
- • Obviousness (35 U.S.C. § 103): Challenges that the claimed method for fraud reduction was obvious in light of prior art.
- • Anticipation (35 U.S.C. § 102): Arguments that prior systems disclosed the patented method.
- • Eligibility (35 U.S.C. § 101): *Alice*/Mayo challenges arguing the claims are directed to abstract ideas without sufficient inventive concept — a particularly potent defense in method patents covering data processing and fraud detection.
Given that US9,972,010 covers a “method, medium, and system” — language frequently scrutinized under § 101 — **patent eligibility** likely formed a central pillar of Apple’s invalidity defense. Federal Circuit jurisprudence under the *Alice Corp. v. CLS Bank* framework has repeatedly invalidated software-implemented fraud detection methods that lack a concrete technical innovation beyond the abstract concept itself.
Strategic Turning Points
The voluntary dismissal under Rule 42(b) with each party bearing its own costs — rather than a cost-shifting order — suggests a mutual agreement, potentially including:
- • A licensing arrangement with confidential terms.
- • Carbyne’s withdrawal following adverse PTAB developments.
- • A strategic decision by Carbyne to avoid a potentially precedent-setting Federal Circuit ruling on the patent’s validity.
Notably, the absence of a fee-shifting order under 35 U.S.C. § 285 (exceptional case doctrine) indicates Apple did not pursue — or did not obtain — attorneys’ fees, which would typically signal the assertion was not deemed objectively baseless.
Legal Significance
Because the case dismissed without a merits opinion, US9,972,010 B1 remains neither judicially confirmed as valid nor invalidated by Federal Circuit ruling. This has direct implications for future assertion strategies: the patent’s legal status is unresolved, preserving both risk and opportunity depending on perspective.
Filing a method patent?
Learn from this case. Use AI to draft stronger claims that can withstand § 101 challenges.
Industry & Competitive Implications
For the Biometric Authentication Market
Apple’s biometric ecosystem — spanning Touch ID, Face ID, and payment authentication — makes it a perennial target for patent assertions in the identity verification space. The dismissal here continues a pattern in which high-profile NPE assertions against Apple resolve before generating binding appellate precedent.
For Patent Assertion Entities
The case reflects ongoing tension in fraud-detection and biometric method patents, where § 101 eligibility challenges create significant litigation risk for patent holders. McKool Smith’s involvement signals Carbyne pursued this appeal with serious litigation infrastructure — suggesting the voluntary dismissal reflected a strategic calculation rather than resource constraints.
Licensing & Settlement Dynamics
The cost-neutral dismissal is consistent with a confidential settlement or licensing resolution — a common outcome when NPEs and major technology defendants seek to avoid the risk of a Federal Circuit invalidity ruling that would extinguish the patent entirely. For Apple, a confidential license at a fraction of potential damages may be economically rational. For Carbyne, preserving the patent’s validity for future assertions may justify settlement over a potential invalidation ruling.
Power Your Patent Strategy with PatSnap Eureka IP
From novelty searches to patent drafting, PatSnap Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in biometric fraud detection. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View the legal status and claim construction of US9,972,010 B1
- See which companies are most active in biometric fraud patents
- Understand § 101 challenges in method patents
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Method patents for biometric fraud detection (under § 101)
1 Patent at Issue
US9,972,010 B1 (Application 13/875,245)
Design-Around Options
Available for most method claims
✅ Key Takeaways
For Patent Attorneys & Litigators
Voluntary Rule 42(b) dismissals with cost-sharing frequently signal confidential licensing resolutions at the Federal Circuit level.
Search related case law →Method patents covering fraud detection remain vulnerable to § 101 *Alice* challenges — ensure claims recite concrete technical improvements.
Explore § 101 precedents →The absence of § 285 fee-shifting suggests Carbyne’s assertion maintained a reasonable legal basis throughout proceedings.
Understand fee-shifting doctrines →For R&D & Product Teams
Biometric authentication methods integrated with fraud reduction workflows carry ongoing patent assertion exposure — conduct FTO analysis against method claims.
Start FTO analysis for my product →Design-around strategies should account for method claims covering multi-step fraud reduction processes in payment and identity systems.
Try AI patent drafting →Future Outlook
Watch for related assertions by Carbyne Biometrics in district courts, and monitor Federal Circuit decisions interpreting § 101 for biometric method patents following *USPTO v. Vidal* guidance updates.
FAQ
What patent was at issue in Carbyne Biometrics v. Apple?
The case involved US Patent No. 9,972,010 B1 (Application No. 13/875,245), covering a method, medium, and system for reducing fraud — a biometric fraud detection technology.
Why was the case dismissed?
The Federal Circuit dismissed proceedings under Fed. R. App. P. 42(b) by mutual agreement of the parties, with each side bearing its own costs. Specific settlement terms were not disclosed.
How does this affect biometric patent litigation broadly?
The dismissal without a merits ruling leaves the patent’s validity unresolved, maintaining litigation uncertainty in biometric fraud detection — a signal for companies to conduct updated freedom-to-operate analyses in this technology space.
Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Product?
Don’t wait for litigation. Check your product’s freedom to operate now.
Run FTO for My Product⚡ Accelerate Your IP Strategy
Join 15,000+ IP professionals using PatSnap Eureka for patent research and analysis.